Clinical Trials Directory

Trials / Completed

CompletedNCT03667638

Influence of Platelet Concentrates on Wound Healing

The Influence of Autologous Platelet Concentrates on Human Keratinocyte Proliferation in Vitro and Wound Healing in Vivo

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Hannover Medical School · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Chronic soft tissues defects can extend into the fat layer or even deeper and can cause functional disadvantages. Split-thickness skin grafts (STSGs) used to cover these wounds have varying success rates. To improve wound healing in chronic wounds the authors have studied the application of autologous platelet concentrates in a human keratinocyte culture model in vitro and in a combination with surgical procedures in vivo as second line therapy in patients with initially failed wound closure.

Detailed description

For in vitro testing on keratinocytes a platelet-mediator concentrate (PMC) was processed with a commercially available bed-side system (ATR®, Curasan, Germany). In a clinical study soft tissue defects (n=5) were treated using a combination of surgical debridement and autologous platelet rich plasma (PRP). Time of healing as determined by epithelization as well as Laser Doppler Imaging to visualize blood flow were analyzed. Additionally, changes in "ease of surgical wound closure" were determined. Finally, the quality of life of patients was assessed using a validated questionnaire.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTPlatelet-Rich PlasmaAdding PRP to wound bed during surgical debridement

Timeline

Start date
2016-11-01
Primary completion
2017-11-01
Completion
2017-12-01
First posted
2018-09-12
Last updated
2018-09-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03667638. Inclusion in this directory is not an endorsement.